Cancer and scleroderma: a paraneoplastic disease with implications for malignancy screening

Area of Science:

• Immunology
• Oncology
• Rheumatology

Background:

• Scleroderma pathogenesis is complex, with emerging evidence suggesting a paraneoplastic mechanism in specific patient groups.
• Autoimmune responses may target tumor-associated antigens, leading to scleroderma development.

Purpose of the Study:

• To review current data on the link between cancer and scleroderma.
• To explore the potential paraneoplastic mechanisms in scleroderma.
• To propose a malignancy screening strategy for at-risk scleroderma patients.

Main Methods:

• Review of recent scientific literature on scleroderma and cancer.
• Analysis of data linking RNA polymerase III autoantibodies to cancer risk.
• Epidemiological data analysis for age-related scleroderma and cancer intervals.

Main Results:

• Patients with scleroderma and RNA polymerase III autoantibodies show a significantly increased cancer risk.
• Somatic mutations in POLR3A are linked to T-cell responses and autoantibody generation.
• Older age at scleroderma onset correlates with a shorter interval to cancer diagnosis, suggesting paraneoplastic disease.

Conclusions:

• Scleroderma can be a paraneoplastic phenomenon in select patients.
• Proactive malignancy screening is crucial for early cancer detection in these individuals.
• Further research is needed to explore if cancer treatment can improve scleroderma outcomes.